Korro Bio, Inc. (KRRO) Operating income 2017–2025
Korro Bio, Inc. (KRRO) annual operating income history from SEC filings — each fiscal year as reported.
-$121.9MFY2025 · since FY2017: -$16.3M → -$121.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$121.9M | -32.6% |
| FY2024 | -$91.9M | -8.7% |
| FY2023 | -$84.5M | -43.3% |
| FY2022 | -$59.0M | +29.8% |
| FY2021 | -$84.0M | -205.0% |
| FY2020 | -$27.6M | -33.3% |
| FY2019 | -$20.7M | -9.1% |
| FY2018 | -$18.9M | -16.2% |
| FY2017 | -$16.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KRRO financial trends
KRRO RevenueKRRO Net incomeKRRO Net marginKRRO Gross profitKRRO Gross marginKRRO Operating marginKRRO Operating cash flowKRRO Free cash flowKRRO Capital expendituresKRRO Return on equityKRRO Stock buybacksKRRO Dividends paidKRRO Total assetsKRRO Total liabilitiesKRRO Shareholders’ equityKRRO overview →